According to this weeks FluView Report from the Centers for Disease Control and Prevention (CDC), influenza-like-illness activity falls in the East but rises sharply in the West.
Overall, during week 4 (Jan. 20-26, 2013), influenza activity remained elevated in the United States, but decreased in some areas. Here are the highlights:
- Viral Surveillance: Of 10,581 specimens tested and reported by collaborating laboratories, 2,701 (25.5 percent) were positive for influenza.
- Pneumonia and Influenza Mortality: The proportion of deaths attributed to pneumonia and influenza was above the epidemic threshold.
- Influenza-Associated Pediatric Deaths: Eight pediatric deaths were reported.
- Influenza-Associated Hospitalizations: A cumulative rate for the season of 25.9 laboratory-confirmed influenza-associated hospitalizations per 100,000 population was reported. Of all hospitalizations, more than 50 percent were among adults 65 years and older.
- Outpatient Illness Surveillance: The proportion of outpatient visits for influenza-like illness (ILI) was 4.2 percent; this is above the national baseline of 2.2 percent. All 10 regions reported ILI above region-specific baseline levels. Twenty-four states and New York City experienced high ILI activity; the District of Columbia and 13 states experienced moderate activity; four states experienced low activity; and nine states experienced minimal activity.
- Geographic Spread of Influenza: Forty-two states reported widespread geographic influenza activity;Â seven states reported regional activity; the District of Columbia and one state reported local activity; Guam reported sporadic influenza activity, and Puerto Rico and theU.S. Virgin Islands did not report.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.